Metallodrugs are unique: Opportunities and challenges of discovery and development
EJ Anthony, EM Bolitho, HE Bridgewater… - Chemical …, 2020 - pubs.rsc.org
Metals play vital roles in nutrients and medicines and provide chemical functionalities that
are not accessible to purely organic compounds. At least 10 metals are essential for human …
are not accessible to purely organic compounds. At least 10 metals are essential for human …
Drug combination in cancer treatment—From cocktails to conjugated combinations
Simple Summary Chemotherapy is a key modality in today's practice of clinical oncology.
The potential for systemic treatment of cancer patients with cytotoxic agents was discovered …
The potential for systemic treatment of cancer patients with cytotoxic agents was discovered …
[HTML][HTML] Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma
T Zhang, B Sun, C Zhong, K Xu, Z Wang… - … lung cancer research, 2021 - ncbi.nlm.nih.gov
Background Intrinsic or acquired resistance to epidermal growth factor receptor-tyrosine
kinase inhibitors (EGFR-TKIs) is common, thus strategies for the management of EGFR-TKIs …
kinase inhibitors (EGFR-TKIs) is common, thus strategies for the management of EGFR-TKIs …
Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma
H Yang, D Xu, RA Schmid… - Therapeutic advances in …, 2020 - journals.sagepub.com
Malignant pleural mesothelioma (MPM) is a lethal thoracic malignancy whose incidence is
still increasing worldwide. MPM is characterized by frequent inactivation of tumor …
still increasing worldwide. MPM is characterized by frequent inactivation of tumor …
Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell …
Background Histone acetylation/deacetylase process is one of the most studied epigenetic
modifications. Histone deacetylase inhibitors (HDACis) have shown clinical benefits in …
modifications. Histone deacetylase inhibitors (HDACis) have shown clinical benefits in …
Pharmacotranscriptomic analysis reveals novel drugs and gene networks regulating ferroptosis in cancer
Simple Summary Ferroptosis is increasingly recognized as a promising avenue for cancer
therapy, while the biomarkers that predict the sensitivity and/or resistance of ferroptosis and …
therapy, while the biomarkers that predict the sensitivity and/or resistance of ferroptosis and …
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma
Malignant pleural mesothelioma (MPM) is a lethal malignancy etiologically caused by
asbestos exposure, for which there are few effective treatment options. Although asbestos …
asbestos exposure, for which there are few effective treatment options. Although asbestos …
Genomics and functional genomics of malignant pleural mesothelioma
E Cakiroglu, S Senturk - International Journal of Molecular Sciences, 2020 - mdpi.com
Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer of the mesothelial cells
lining the pleural surface of the chest wall and lung. The etiology of MPM is strongly …
lining the pleural surface of the chest wall and lung. The etiology of MPM is strongly …
Ropivacaine inhibits the growth, migration and invasion of gastric cancer through attenuation of WEE1 and PI3K/AKT signaling via miR-520a-3p
N Zhang, X Xing, F Gu, G Zhou, X Liu… - OncoTargets and …, 2020 - Taylor & Francis
Background Metastasis remains one of the greatest challenges involved in treating gastric
cancer (GC). Ropivacaine (Rop) is not only a well-documented local anesthetic medicament …
cancer (GC). Ropivacaine (Rop) is not only a well-documented local anesthetic medicament …
Organoids as a model for precision medicine in malignant pleural mesothelioma: where are we today?
Y Gao, M Kruithof-de Julio, RW Peng, P Dorn - Cancers, 2022 - mdpi.com
Simple Summary Malignant pleural mesothelioma (MPM) is an extremely lethal cancer,
notoriously known for its limited treatment options, lack of targeted therapies, and …
notoriously known for its limited treatment options, lack of targeted therapies, and …